365106250 | emc | 80689410 | | 0835419 | 9/27/2005 12:00:00 am | 1 ) angina , r/o mi. | | dis | admission date: 6/26/2005 report status:discharge date: 7/15/2005 final discharge orders continenza , whitney a. 678-61-28-1rockservice: cardischarge patient on: 10/18/05 at 01:00 pmcontingent upon not applicablewill d/c order be used as the d/c summary: yesattending: birkey , merlin keven , m.d.code status:full codedisposition: homedischarge medications:ecasa ( aspirin enteric coated ) 81 mg po qdstarting today ( 8/25 )ferrous sulfate 325 mg po tidfood/drug interaction instruction avoid milk and antacidlasix ( furosemide ) 60 mg po bidhydralazine hcl 90 mg po tid starting today ( 1/3 )hold if: sbp <95 food/drug interaction instructiontake consistently with meals or on empty stomach.labetalol hcl 600 mg po tid hold if: sbp<90 , hr<50food/drug interaction instructiontake consistently with meals or on empty stomach.nitroglycerin 1/150 ( 0.4 mg ) 1 tab sl q5min x 3prn chest pain hold if: sbp < 100claritin ( loratadine ) 10 mg po qdfood/drug interaction instructionavoid grapefruit unless md instructs otherwise.give on an empty stomach ( give 1hr before or 2hr afterfood )cozaar ( losartan ) 100 mg po qd hold if: sbp 95number of doses required ( approximate ): 3metformin 850 mg po bidvytorin 10/40 ( ezetimibe 10 mg - simvastatin ... )1 tab po qddiet: patient should measure weight dailydiet: house / low chol/low sat. fatdiet: house / ada 1800 cals/dydiet: 2 gram sodiumactivity: resume regular exercisefollow up appointment( s ):dr. rob mulroy 1 wk. ,allergy: latexadmit diagnosis:1 )atypical chest pain 2 ) htn 3 ) niddm 4 ) hypercholesterolemia 5 ) h/orenal cell carcinoma s/p resection.principal discharge diagnosis ;responsible after study for causing admission )1 ) angina , r/o mi.other diagnosis;conditions , infections , complications , affecting treatment/stayhypertension s/p mva -> rle frx ( 1977 ) s/p rle skin graft( 1977 ) medical non-compliance obesity ? hypercholesterolemiaoperations and procedures:noneother treatments/procedures ( not in o.r. )adenosine mibi: ( preliminary report ) poor quality study due to bodyhabitus. lvef 44%. lv dilated. no perfusion defects.brief resume of hospital course:cc:chest painhpi: 43 yo m w/hx of htn , dm p/w atypical cp , concerning for unstableangina. p/w 1 day h/o l sided dull cp radiating to his l arm , started5/10 .  started at rest , remained for 4 hrs. +diaphoresis , +nausea ,mild sob. cardiac rf include dm , htn , hyperchol , fh , h/o smoking. tniat ash neg - 0.04 and 0.05 but continued pain requiring ntg drip. ekgwith twi concerning for anterolateral ischemia. initiatedon heparin , transferred to m for management , possible cath.----------------------------------pmh: chf ( dxed 1997 while actively using cocaine ) , htn ,hypercholesterolemia , renal cell carcinoma s/p resection.------------status: ( at admission ) t100.5 p 82 r 18 bp 148/70 pox 99% 2l. gen:pleaseant obese m , nad. cv: rrr , i/vi sem lsb , +s3. resp: ctab , ab:soft , nt , mild distended. ext: trace edema bilateral. guaic , no stoolin vault.---procedures/tests: labs: trop osh 0.04 , 0.05 , k2.9 , hct 35.5 , creat2.0 ekg: nsr , lvh with repolarization , twi ii , iii , fv4-6. cxr: 9/16: cardiomegaly , mild pul vasculature engorgement.no acute pul infiltrate. adenosine mibi: 10/18 poor quality study due tobodyhabitus. ef 44%. lv dilated. no perfusion defects.---a/p: 43 m admitted with atypical chest pain. concern for unstableangina/nstemi.1.cv ischemia: significant cardiac hx with borderline tni at ash( 0.04-0.05 ). admitted to wo , started on heparin , asa , bb( labetalol ) , statin , arb ( angioedema w/ace ) , ntg drip , o2. remainedchest pain free overnight. on 9/10 , ntg drip tapered , hydralazine andlabetalol increased. pt underwent mibi , notable for lv dilation , ef44% , no perfusion defects. pt remained overnight to ensure adequatebp with new medications. will likely need continued titration ofantihypertensives.pump: chf: euvolemic; lvef 44% via mibi. bp control as above.renal: cri at baseline cr of 2.0. renal dose meds.2. endo: metformin held , nph and novolog ssi initiated for bs control. fsac , excellent bs with range 110-150.3. id: low grade temps - ua negative , cxr negative. no signs of systemicillness.4. gi: h/o hematochezia , no stool on dre. guiac stools x 3 as on heparin.5. fen: sliv. replete electrolytes aggressively. cardiac diet.6. resp: stable. supp o2 prnfull codecodeadditional comments: call dr. racioppo ( 925 ) 590 4260 upon discharge to schedule an appt within1 wk. bring this document to the appt. comply with low chol , low fat , <2gsodium diet. weigh yourself daily , if you gain more than 2 lbs in 1 day or5 lbs in a week contact your doctor as this is a symptom of chf. continueyour discharge medications as advised. do not resume the norvasc orenalapril until instructed to do so by dr. kozola . seek medical attentionfor worsening chest pain , shortness of breath marked weight gain.discharge condition: stableto do/plan:1 ) f/u with dr pulfrey within 1 wk for bp check. may need medicationtitration including reinstitution of norvasc.consider further w/u anemia( ida +/- aocd ). pt has a h/o hematochezia , unclear when priorcolonoscopy.no dictated summaryentered by: bernt , shon a. , m.d. , ph.d. ( oj43 ) 10/18/05 @ 11:38 am end of discharge orders 